Nelson Asofa-Solomona and Paul Gallen will not undergo drug testing ahead of their heavyweight boxing match scheduled for November 6 in Sydney, despite ongoing discussions about the issue. Gallen has expressed willingness to be tested prior to the fight and questioned why drug testing was not included in the contractual agreements.

Asofa-Solomona, 30, faces pressure as the bout carries significant stakes for his professional boxing aspirations. His contract includes a clause allowing the promoter, No Limit, to sever their partnership if he loses. With Gallen's record standing at 16 wins, 2 losses, and 1 draw, Asofa-Solomona must secure a victory to maintain his trajectory in the sport.

Throughout the weeks leading up to the fight, Asofa-Solomona has repeatedly been asked about the absence of drug tests. However, he has dismissed concerns, stating he has been avoiding the topic despite public calls for commentary, especially amid Gallen’s accusations labeling him a quitter. Asofa-Solomona remarked that no testing protocol has been established and suggested that regardless of any substances, the outcome of the fight would not be affected.

Gallen, a former Cronulla Sharks player, has a history tied to a peptide controversy more than ten years ago but has never failed any drug tests and continues to assert his innocence. He expressed frustration at frequent references to doping allegations by opponents, reiterating his openness to drug testing at any time.

The personal rivalry between the two athletes has also fueled verbal exchanges. Gallen has indicated his intention to halt Asofa-Solomona’s boxing career with a win but dismissed his rival’s psychological tactics as baseless. Asofa-Solomona has fired back at Gallen’s insults, which have included calling him derogatory names, and invited the public to compare their reputations, implying his own character is stronger.

As the fight approaches, the drug testing controversy remains unresolved, with neither fighter undergoing any formal screening before the contest. The match is set to attract significant attention, not only for the athletic competition but also for the surrounding disputes over testing and professionalism.